Havana city, Cuba.- The president of Cuba, Miguel Díaz-Canel, praised today the work of the island’s scientists involved in obtaining vaccines against Covid-19, newspaper Granma reported today in its digital version. During his third visit to the Finlay Vaccine Institute (IFV), this Monday, the president was informed about the state of progress of the Sovereign […]
Cuban scientists started the second phase of clinical trial on the Soberana 02 vaccine on Tuesday, when the first volunteers were vaccinated.
A new company with foreign capital will produce more electricity in Cuba from renewable sources, representatives of an official organization said.
Cuba has registered four vaccine candidates against Covid-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.
Cuban Permanent Delegate at UNESCO Yahima Esquivel on Tuesday expressed her country’s support for artificial intelligence development from an ethical perspective.
The government of Havana and the European Union (EU) signed collaboration deals to fight the Covid-19 pandemic, local media highlighted on Monday.
A workshop on the challenges of the hydraulic sector in Cuba stands out in the program of the 1st International Conference on Blue Innovation (Innovazul-2020) scheduled from December 3 to 5, organizers said.
The World Travel and Tourism Council (WTTC) reported the Covid-19 pandemic affected tourism by 65%.
Prime Minister Manuel Marrero urged in this Cuban province to strictly comply with biosafety protocols in tourist facilities to avoid a possible Covid-19 outbreak.
A session of debates and proposals on the challenges of science in Cuba for the development of society will end on Friday after four days of meetings among academics, researchers, professors and students of this country.
Cuba’s Center for Molecular Immonology (CIM) announced the start of a new phase I and II study to assess the safety and effect of the therapeutic antibody Itolizumab in patients with sepsis.
The clinical severity in patients with Covid-19 could vary due to genetic risk factors, indicates a research develop today by experts from the National Center of Medical Genetics of Cuba.
Manuel Marrero Cruz, Prime Minister of Cuba, met on Monday with members of the “Henry Reeve” Brigade that supported the fight against COVID-19 in Mexico for three months.
The BioCubaFarma Business Group and the UK company Sg Innovations Limited announced on Monday the creation of a new company, BioFarma Innovations, focused on accelerating the development and accessibility in Europe and the British Commonwealth of innovative and leading world-class medicines, reports a joint statement from both entities, to which Granma was granted access.
Cuba today rejected the action of the de facto Government of Bolivia with respect to a clinic owned by the island in La Paz, for ignoring its rights over this and the provisions of international law.
The Universidad de Oriente (UO) is currently preparing the 23rd Chemistry Conference, the oldest event of this science in the country, which will take place in this city next November and will update last developments on these fields of knowledge.
Cuban President Miguel Diaz-Canel on Tuesday recognized the science contribution impacts to fight the Covid-19 pandemic.
Cuban scientists will not rest, there is a commitment to science and the people to eradicate the novel SARS-CoV-2 coronavirus, a Cuban expert said.
Cuban health authorities today denied the existence of heart defects in children confirmed with Covid-19, on the contrary, they have had a favorable evolution, they said.
